Autoimmune and cholestatic liver diseases frequently present with overlapping clinical features, such as fatigue, pruritus, jaundice, and elevated alkaline phosphatase or transaminases. Accurate non-invasive diagnosis often relies on the identification of specific circulating autoantibodies. Match each hepatobiliary disorder with its most characteristic diagnostic serological marker.
- Primary biliary cholangitisAnti-mitochondrial antibodies (AMA)
- Primary sclerosing cholangitisPerinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA)
- Type 1 Autoimmune hepatitisAnti-smooth muscle antibodies (ASMA)
- Type 2 Autoimmune hepatitisAnti-liver kidney microsome type 1 (anti-LKM1) antibodies
Answer
Primary biliary cholangitis matches with Anti-mitochondrial antibodies (AMA). Primary sclerosing cholangitis matches with Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA). Type 1 Autoimmune hepatitis matches with Anti-smooth muscle antibodies (ASMA). Type 2 Autoimmune hepatitis matches with Anti-liver kidney microsome type 1 (anti-LKM1) antibodies.
Each hepatobiliary condition has a distinct, classic autoantibody profile that is critical for non-invasive diagnosis. AMA is highly sensitive and specific for Primary biliary cholangitis. p-ANCA is frequently found in Primary sclerosing cholangitis, reflecting its underlying immunological relationship with ulcerative colitis. Autoimmune hepatitis is divided into Type 1 (ASMA and/or ANA positive) and Type 2 (anti-LKM1 positive).
Step-by-Step Solution
Key Concept
Serological Markers of Autoimmune Hepatobiliary Disease